tradingkey.logo
tradingkey.logo
Search

TherapeuticsMD Inc

TXMD
Add to Watchlist
2.030USD
0.0000.00%
Close 07-31 16:00ETQuotes delayed by 15 min
23.50MMarket Cap
130.46P/E TTM

TXMD Financials

See TherapeuticsMD Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

TherapeuticsMD Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
3.02M
71.61%
EPS(YoY)
-0.05
74.00%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
114.52%0.01
-344.76%-0.05
124.86%0.01
150.37%0.05
11.19%-0.06
127.32%0.02
83.27%-0.05
59.99%-0.09
82.77%-0.06
-100.98%-0.08
---0.32
---0.24
---0.37
--8.20
--3.86
----
----
----
----
----
Revenue
84.22%724.00K
33.88%893.00K
43.33%784.00K
306.84%952.00K
25.56%393.00K
32.87%667.00K
1132.08%547.00K
-46.45%234.00K
-24.76%313.00K
-56.42%502.00K
-114.97%-53.00K
25.57%437.00K
-40.14%416.00K
-93.83%1.15M
-98.61%354.00K
-98.49%348.00K
-96.50%695.00K
-17.27%18.68M
31.35%25.41M
114.94%23.00M
Net Profit
114.55%95.00K
-345.63%-619.00K
124.96%152.00K
150.55%551.00K
11.04%-653.00K
128.54%252.00K
81.97%-609.00K
54.85%-1.09M
79.63%-734.00K
-101.14%-883.00K
88.34%-3.38M
-102.15%-2.41M
92.65%-3.60M
280.87%77.70M
38.92%-28.96M
363.25%112.28M
-24.47%-49.02M
-2.07%-42.96M
-45.41%-47.42M
17.94%-42.65M
Net Margin
108.79%14.23%
-500.98%-68.53%
106.15%6.38%
112.76%57.25%
37.39%-161.83%
105.57%17.09%
---103.66%
18.77%-448.72%
53.45%-258.47%
89.36%-306.97%
----
---552.40%
---555.29%
---2883.77%
---3391.48%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
471.85%100.00%
--100.00%
41.42%100.00%
6.94%100.00%
-102.36%-26.89%
----
--70.71%
--93.51%
--1140.89%
---63.28%
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00%
--69.90%
----
----
----
----
----
Revenue
84.22%724.00K
33.88%893.00K
43.33%784.00K
306.84%952.00K
25.56%393.00K
32.87%667.00K
1132.08%547.00K
-46.45%234.00K
-24.76%313.00K
-56.42%502.00K
-114.97%-53.00K
25.57%437.00K
-40.14%416.00K
-93.83%1.15M
-98.61%354.00K
-98.49%348.00K
-96.50%695.00K
-17.27%18.68M
31.35%25.41M
114.94%23.00M
Operating profit
7.66%-723.00K
-379.49%-1.50M
3.38%-830.00K
41.05%-695.00K
31.44%-783.00K
80.63%-312.00K
51.55%-859.00K
52.31%-1.18M
57.18%-1.14M
-102.11%-1.61M
87.79%-1.77M
83.36%-2.47M
85.08%-2.67M
352.48%76.48M
55.49%-14.52M
57.77%-14.86M
38.95%-17.88M
11.06%-30.29M
-33.76%-32.62M
21.89%-35.18M
Net Profit
114.55%95.00K
-345.63%-619.00K
124.96%152.00K
150.55%551.00K
11.04%-653.00K
128.54%252.00K
81.97%-609.00K
54.85%-1.09M
79.63%-734.00K
-101.14%-883.00K
88.34%-3.38M
-102.15%-2.41M
92.65%-3.60M
280.87%77.70M
38.92%-28.96M
363.25%112.28M
-24.47%-49.02M
-2.07%-42.96M
-45.41%-47.42M
17.94%-42.65M
Current assets
21.99%15.26M
17.83%14.45M
19.33%14.50M
13.85%13.46M
8.58%12.51M
3.93%12.26M
-30.31%12.15M
-39.72%11.82M
-53.41%11.52M
-78.69%11.80M
-80.06%17.44M
-80.11%19.61M
-70.70%24.73M
-53.67%55.35M
-45.32%87.48M
-38.24%98.60M
-54.86%84.42M
-6.96%119.47M
30.65%159.98M
7.19%159.66M
Total current liabilities
3.59%4.91M
-7.38%4.79M
-17.25%4.95M
-19.83%4.66M
-26.70%4.74M
-24.63%5.17M
-58.82%5.98M
-59.52%5.81M
-66.55%6.47M
-85.37%6.85M
-91.66%14.51M
-91.24%14.36M
-92.70%19.34M
-81.48%46.84M
101.78%174.07M
116.70%163.99M
332.14%264.83M
326.91%252.89M
82.26%86.27M
62.80%75.67M
Total assets
-1.71%37.58M
-3.00%37.66M
-2.23%38.67M
-4.04%38.50M
-9.15%38.24M
-10.36%38.82M
-21.67%39.55M
-25.26%40.13M
-29.38%42.09M
-52.12%43.31M
-62.29%50.49M
-63.28%53.69M
-55.32%59.60M
-46.62%90.46M
-36.12%133.91M
-30.58%146.20M
-44.26%133.38M
-6.68%169.47M
18.24%209.63M
2.46%210.60M
Total liabilities
-7.72%10.61M
-5.87%10.78M
-9.88%11.23M
-9.99%11.21M
-14.36%11.50M
-18.33%11.45M
-44.49%12.46M
-44.62%12.46M
-51.32%13.42M
-74.65%14.02M
-87.68%22.44M
-86.94%22.49M
-89.93%27.58M
-78.98%55.31M
-31.77%182.18M
-33.66%172.27M
10.12%273.96M
-13.91%263.09M
-8.98%266.99M
-13.33%259.68M
Total equity
0.87%26.97M
-1.80%26.88M
1.29%27.44M
-1.37%27.29M
-6.71%26.74M
-6.55%27.37M
-3.42%27.09M
-11.31%27.67M
-10.49%28.66M
-16.66%29.29M
158.11%28.05M
219.68%31.20M
122.78%32.02M
137.54%35.14M
15.85%-48.27M
46.88%-26.07M
-1383.22%-140.58M
24.50%-93.62M
50.57%-57.36M
47.84%-49.07M
Net operating income
35.05%944.00K
2105.88%375.00K
1507.04%999.00K
-73.78%381.00K
405.24%699.00K
100.34%17.00K
98.82%-71.00K
142.84%1.45M
97.37%-229.00K
-106.78%-4.96M
-134.03%-6.03M
83.63%-3.39M
51.31%-8.70M
52.51%73.21M
146.35%17.72M
21.90%-20.72M
53.43%-17.87M
258.31%48.00M
-12.26%-38.22M
52.58%-26.53M
Net investment
----
----
----
----
----
----
----
----
----
100.00%0.00
-100.00%0.00
100.00%0.00
100.00%0.00
-9323.45%-142.67M
103.85%7.00K
14.61%-76.00K
51.60%-212.00K
-186.07%-1.51M
30.53%-182.00K
77.69%-89.00K
Net financing
----
----
----
----
----
-100.00%0.00
----
----
----
101.54%2.00M
-100.06%-1.00K
100.96%1.15M
100.00%0.00
-9704.43%-129.95M
-94.54%1.74M
-28137.38%-120.00M
-105.21%-5.00M
-95.73%1.35M
29920.75%31.82M
355.85%428.00K

FAQs

What is the total revenue of TherapeuticsMD Inc?

According to TherapeuticsMD Inc's FY2025 earnings report, its total revenue reached 3.02M, with a year-on-year change of 1.76M.

What are the current assets of TherapeuticsMD Inc?

According to TherapeuticsMD Inc's FY2025 earnings report, its current assets were 14.45M, with a year-on-year change of 17.83.

What are the total assets of TherapeuticsMD Inc?

According to TherapeuticsMD Inc's FY2025 earnings report, its total assets of TherapeuticsMD Inc were 37.66M, with a year-on-year change of -3.00.

What are the total liabilities of TherapeuticsMD Inc?

According to TherapeuticsMD Inc's FY2025 earnings report, its total liabilities of TherapeuticsMD Inc were 10.78M, with a year-on-year change of -5.87.

What is the total equity of TherapeuticsMD Inc?

According to TherapeuticsMD Inc's FY2025 earnings report, its total equity of TherapeuticsMD Inc was 26.88M, with a year-on-year change of -1.80.

What is the net operating income of TherapeuticsMD Inc?

According to TherapeuticsMD Inc's FY2025 earnings report, its net operating income of TherapeuticsMD Inc was -4.21M, with a year-on-year change of 13.01.

What is the Earnings Per Share (EPS) of TherapeuticsMD Inc?

According to TherapeuticsMD Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.05, with a year-on-year change of 74.00.

What is the net income of TherapeuticsMD Inc?

According to TherapeuticsMD Inc's FY2025 earnings report, its net income was -569.00K, with a year-on-year change of 73.91.

What is the net margin of TherapeuticsMD Inc?

According to TherapeuticsMD Inc's FY2025 earnings report, its net profit margin was -21.61, with a year-on-year change of 83.54.

What is the Return on Equity (ROE) of TherapeuticsMD Inc?

According to TherapeuticsMD Inc's FY2025 earnings report, its Return on Equity (ROE) was -2.41, with a year-on-year change of 70.50.

What is the Return on Assets (ROA) of TherapeuticsMD Inc?

According to TherapeuticsMD Inc's FY2025 earnings report, its Return on Assets (ROA) was -1.71, with a year-on-year change of 69.67.

What is the operating profit of TherapeuticsMD Inc?

According to TherapeuticsMD Inc's FY2025 earnings report, its operating profit was -4.21M, with a year-on-year change of 13.01.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.